{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T20:08:08Z","timestamp":1698091688398},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[1990,4,1]],"date-time":"1990-04-01T00:00:00Z","timestamp":638928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Agents and Actions"],"published-print":{"date-parts":[[1990,4]]},"DOI":"10.1007\/bf01969027","type":"journal-article","created":{"date-parts":[[2005,8,2]],"date-time":"2005-08-02T15:32:11Z","timestamp":1122996731000},"page":"161-165","source":"Crossref","is-referenced-by-count":1,"title":["Cytochrome P-450 metabolic-intermediate complex formation with a series of diphenhydramine analogues"],"prefix":"10.1007","volume":"30","author":[{"given":"A.","family":"Bast","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J.","family":"Valk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Timmerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01969027_CR1","first-page":"227","volume":"3","author":"M. R. Franklin","year":"1977","unstructured":"M. R. Franklin,Inhibition of mixed-function oxidations by substrates forming reduced cytochrome P-450 metabolic-intermediate complexes. Pharmacol. Ther. Part A3, 227\u2013245 (1977).","journal-title":"Pharmacol. Ther. Part A"},{"key":"BF01969027_CR2","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/jps.2600730723","volume":"73","author":"A. Bast","year":"1984","unstructured":"A. Bast, E. M. Savenije-Chapel and J. Noordhoek,Relationship between molecular structure and cytochrome P-450-metabolic intermediate complex formation. J. Pharm. Sci.73, 953\u2013956 (1984).","journal-title":"J. Pharm. Sci."},{"key":"BF01969027_CR3","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1021\/jm00369a018","volume":"27","author":"U. B. Paulsen-S\u00f6rman","year":"1984","unstructured":"U. B. Paulsen-S\u00f6rman, K.-H. J\u00f6nssen and B. G. A. Lindeke,Cytochrome P-455 nm complex formation in the metabolism of phenylalkylamines 8. Stereoselectivity in metabolic intermediary complex formation with a series of chiral 2-substituted 1-phenyl-2-aminoethanes. J. Med. Chem.27, 342\u2013346 (1984).","journal-title":"J. Med. Chem."},{"key":"BF01969027_CR4","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1016\/0006-2952(82)90128-9","volume":"31","author":"A. Bast","year":"1982","unstructured":"A. Bast and J. Noordhoek,Spectral interactions of orphenadrine and its metabolites with oxidized and reduced hepatic microsomal cytochrome P-450 in the rat. Biochem. Pharmacol.31, 2745\u20132753 (1982).","journal-title":"Biochem. Pharmacol."},{"key":"BF01969027_CR5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF01261381","volume":"54","author":"A. Bast","year":"1983","unstructured":"A. Bast, E. M. Savenije-Chapel, F. A. A. van Kemenade, L. W. C. Scheefhals and J. Noordhoek,Effect of multiple administration of orphenadrine or mono-N-desmethylorphenadrine on cytochrome P-450 catalyzed reactions in the rat. Arch. Toxicol.54, 131\u2013137 (1983).","journal-title":"Arch. Toxicol."},{"key":"BF01969027_CR6","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0006-2952(79)90239-9","volume":"28","author":"M. Hirata","year":"1979","unstructured":"M. Hirata, B. Lindeke and S. Orrenius,Cytochrome P-450 product complexes and glutathione consumption produced in isolated hepatocytes by norbenzphetamine and its N-oxidized congeners. Biochem. Pharmacol.28, 479\u2013484 (1979).","journal-title":"Biochem. Pharmacol."},{"key":"BF01969027_CR7","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/0006-2952(86)90594-0","volume":"35","author":"D. Larrey","year":"1986","unstructured":"D. Larrey, M. Tinel, P. Letteron, J. Geneve, V. Descatoire and D. Pessayre,Formation of an inactive cytochrome P-450Fe(II)-metabolite complex after administration of amiodarone in rats, mice and hamsters. Biochem. Pharmacol.35, 2213\u20132220 (1986).","journal-title":"Biochem. Pharmacol."},{"key":"BF01969027_CR8","first-page":"391","volume":"40","author":"A. Bast","year":"1983","unstructured":"A. Bast, F. A. A. van Kemenade, E. M. Savenije-Chapel and J. Noordhoek,Product inhibition in orphenadrine metabolism as a result of a stable cytochrome P-450-metabolic intermediate complex formed during the disposition of mono-N-desmethylorphenadrine (tofenacine) in the rat. Res. Commun. Chem. Pathol. Pharmacol.40, 391\u2013403 (1983).","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"BF01969027_CR9","first-page":"479","volume":"14","author":"R. F. Rekker","year":"1979","unstructured":"R. F. Rekker and H. M. de Kort,The hydrophobic fragmental constant; an extension to a 1000 data point set. Eur. J. Med. Chem.14, 479\u2013488 (1979).","journal-title":"Eur. J. Med. Chem."},{"key":"BF01969027_CR10","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3109\/00498258209038944","volume":"12","author":"L. K. Pershing","year":"1982","unstructured":"L. K. Pershing and M. R. Frankling,Cytochrome P-450 metabolic-intermediate complex formation and induction by macrolide antibiotics; a new class of agents. Xenobiotica12, 687\u2013699 (1982).","journal-title":"Xenobiotica"},{"key":"BF01969027_CR11","first-page":"415","volume":"17","author":"M. R. Franklin","year":"1980","unstructured":"M. R. Franklin, C. R. Wolf, C. Serabjit-Singh, R. M. Philpot,Quantitation of two forms of pulmonary cytochrome P-450 in microsomes, using substrate specificities. Mol. Pharmacol.17, 415\u2013420 (1980).","journal-title":"Mol. Pharmacol."},{"key":"BF01969027_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/03602537208993906","volume":"1","author":"C. Hansch","year":"1972","unstructured":"C. Hansch,quantitative relationships between lipophilic character and drug metabolism. Drug Metab. Rev.1, 1\u201313 (1972).","journal-title":"Drug Metab. Rev."},{"key":"BF01969027_CR13","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/0006-2952(83)90470-7","volume":"32","author":"D. Larrey","year":"1983","unstructured":"D. Larrey, M. Tinel and D. Pessayre,Formation of inactive cytochrome P-450Fe(II) metabolic complexes with several erythromycin derivatives but not with josamycin and midecamycin in rats. Biochem. Pharmacol.32, 1487\u20131493 (1983).","journal-title":"Biochem. Pharmacol."}],"container-title":["Agents and Actions"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01969027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01969027\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01969027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T18:04:43Z","timestamp":1557770683000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01969027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,4]]},"references-count":13,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[1990,4]]}},"alternative-id":["BF01969027"],"URL":"https:\/\/doi.org\/10.1007\/bf01969027","relation":{},"ISSN":["0065-4299","1420-908X"],"issn-type":[{"value":"0065-4299","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,4]]}}}